Revised International Prognostic Index
The Revised International Prognostic Index is used to determine prognosis in PATIENTS with Diffuse Large B-cell Lymphoma (DLBCL).
Description
The Revised International Prognostic Index (R-IPI) is an ASSESSMENT TOOL.
The Revised International Prognostic Index is used to determine prognosis in PATIENTS with Diffuse Large B-cell Lymphoma (DLBCL).
For further information on the Revised International Prognostic Index, see the Revised International Prognostic Index calculator.
Also Known As
This NHS business definition is also known by these names:
Context | Alias |
---|---|
Short name | R-IPI |
Where Used
Type | Link | How used |
---|---|---|
Data Element | REVISED INTERNATIONAL PROGNOSTIC INDEX SCORE | references in description Revised International Prognostic Index |
NHS Business Definition | Revised International Prognostic Index | references in description Revised International Prognostic Index |